EPIEN Medical, Inc. (EPMI)
EPIEN Medical was planning to go public, but the IPO was withdrawn on Mar 21, 2023.
IPO Price Range
$4.25 - $6.25
Shares Offered
4,190,476
Deal Size
$22.00M
EPIEN Medical Statistics
Total Valuation
EPIEN Medical has a market cap or net worth of $74.13 million. The enterprise value is $81.87 million.
Market Cap | 74.13M |
Enterprise Value | 81.87M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
EPIEN Medical has 14.12 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 14.12M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 58.24 |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 64.33 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -2.30 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | $97,908 |
Profits Per Employee | -$292,186 |
Employee Count | 13 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EPIEN Medical had revenue of $1.27 million and -$3.80 million in losses. Loss per share was -$0.27.
Revenue | 1.27M |
Gross Profit | 964,963 |
Operating Income | -2.64M |
Pretax Income | -3.80M |
Net Income | -3.80M |
EBITDA | -2.51M |
EBIT | -2.65M |
Loss Per Share | -$0.27 |
Balance Sheet
Cash & Cash Equivalents | n/a |
Total Debt | 7.75M |
Net Cash | -7.75M |
Net Cash Per Share | -$0.55 |
Equity (Book Value) | -14.32M |
Book Value Per Share | -1.01 |
Working Capital | -11.96M |
Cash Flow
In the last 12 months, operating cash flow was -$2.14 million and capital expenditures -$61,121, giving a free cash flow of -$2.20 million.
Operating Cash Flow | -2.14M |
Capital Expenditures | -61,121 |
Free Cash Flow | -2.20M |
FCF Per Share | -$0.16 |
Margins
Gross margin is 75.81%, with operating and profit margins of -207.34% and -298.43%.
Gross Margin | 75.81% |
Operating Margin | -207.34% |
Pretax Margin | -298.43% |
Profit Margin | -298.43% |
EBITDA Margin | -197.34% |
EBIT Margin | -208.02% |
FCF Margin | -173.23% |
Dividends & Yields
EPIEN Medical does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -5.12% |
FCF Yield | -2.97% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |